Understanding long-term effects and systemic impact
Exploring connections between infection, inflammation, and cognitive decline
Investigating multi-system drivers of long-term symptoms
Recent research supported by the Foundation has demonstrated:
Reversal of Alzheimer’s-related biomarkers in patients with chronic Lyme disease using targeted treatment approaches.
This represents a potential shift in how neurodegenerative conditions are studied and treated.